![Liana Patt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Liana Patt
Directeur Général chez
FutuRx Ltd.
Profil
Liana Patt currently works at FutuRx Ltd., as Chief Executive Officer from 2022, Lipomedix Pharmaceuticals Ltd., as Director, Ayana Pharma Ltd., as Director, GliXogen Therapeutics Ltd., as Director from 2022, and HighRAD Ltd., as Director.
Dr. Patt also formerly worked at Integra Holdings Ltd., as Chief Executive Officer, Atox Bio Ltd., as Director, and Teva Pharmaceutical Industries Ltd., as Vice President-Global Business Development.
Dr. Patt received her undergraduate degree in 1989 from Tel-Aviv University, doctorate degree from Weizmann Institute of Science, and Masters Business Admin degree from Edinburgh Business School.
Postes actifs de Liana Patt
| Sociétés | Poste | Début |
|---|---|---|
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Directeur/Membre du Conseil | - |
HighRAD Ltd.
 HighRAD Ltd. Packaged SoftwareTechnology Services Operates as an oncology AI imaging platform for clinical applications | Directeur/Membre du Conseil | - |
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products | Directeur/Membre du Conseil | 08/06/2022 |
Ayana Pharma Ltd.
 Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the development of liposomal therapeutics for the treatment of cancer | Directeur/Membre du Conseil | - |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Directeur Général | 01/05/2022 |
Anciens postes connus de Liana Patt
| Sociétés | Poste | Fin |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Directeur Général | - |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Directeur/Membre du Conseil | - |
Formation de Liana Patt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Integra Holdings Ltd.
Integra Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
Edinburgh Business School
 Edinburgh Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Ayana Pharma Ltd.
Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the development of liposomal therapeutics for the treatment of cancer | Health Technology |
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products | Commercial Services |
HighRAD Ltd.
HighRAD Ltd. Packaged SoftwareTechnology Services Operates as an oncology AI imaging platform for clinical applications | Technology Services |
